The CEO of Pfizer said: “There are more than 5 million deaths worldwide, countless lives are affected by this devastating disease, and life-saving treatments are urgently needed.” Albert BurlaThe effectiveness of the pills shown in clinical studies shows that antiviral drugs in the form of pills can “play a central role in the fight against Covid-19”.
Pfizer said a week and a half ago that paxlovid has reduced the likelihood of hospitalization or death of high-risk patients infected with the coronavirus by 89%. The patient took the pill every twelve hours for five days.
Cheaper in poorer countries
Several pharmaceutical companies are currently developing drugs to reduce the impact of infection coronavirus ease. The British Medicines Agency recently approved the Molnupiravir drug from the American pharmaceutical company Merck Sharp & Dohme (MSD) for the treatment of Covid patients with mild to moderate disease.
Paxlovid and molnupiravir reduce the ability of the virus to reproduce in human cells, thereby slowing the further development of the Covid-19 disease. The advantage of these pills is that they are easy to take at home. On the other hand, other drugs, such as the antiviral drug Remdesivir, must be injected intravenously.
Pfizer announced on Tuesday that after approval, it will provide this new corona drug at a cheaper price in poorer countries. The group announced an agreement to sublicense generic drug manufacturers to produce such pills without paying royalties.
